AhR and Cancer: From Gene Profiling to Targeted Therapy - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue International Journal of Molecular Sciences Année : 2021

AhR and Cancer: From Gene Profiling to Targeted Therapy

Résumé

The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that has been shown to be an essential regulator of a broad spectrum of biological activities required for maintaining the body’s vital functions. AhR also plays a critical role in tumorigenesis. Its role in cancer is complex, encompassing both pro- and anti-tumorigenic activities. Its level of expression and activity are specific to each tumor and patient, increasing the difficulty of understanding the activating or inhibiting roles of AhR ligands. We explored the role of AhR in tumor cell lines and patients using genomic data sets and discuss the extent to which AhR can be considered as a therapeutic target.
Fichier principal
Vignette du fichier
preprints202011.0261.v1.pdf (2.1 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03134830 , version 1 (08-02-2021)

Licence

Paternité

Identifiants

Citer

Anaïs Paris, Nina Tardif, Marie-Dominique Galibert, Sébastien Corre. AhR and Cancer: From Gene Profiling to Targeted Therapy. International Journal of Molecular Sciences, 2021, 22 (2), ⟨10.3390/ijms22020752⟩. ⟨hal-03134830⟩
62 Consultations
78 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More